Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Syncona Portfolio Limited investment portfolio
Syncona Portfolio Limited has made numerous investments in companies such as Resolution Therapeutics, Biomodal, and Quell Therapeutics within the Biotech sector.
unknown
Portfolio
17
Team
0
Portfolio (17)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Achilles Therapeutics Uk Limited Achilles Therapeutics UK Limited is a biopharmaceutical company that develops personalized T‑cell immunotherapies targeting patient‑specific neoantigens, with the aim of treating cancer. | Healthcare & Life Sciences | Birmingham | Confirmed | 2024-11-19 |
| Beacon Therapeutics Holdings Limited Beacon Therapeutics Holdings Limited develops and advances gene‑therapy treatments for retinal diseases that cause blindness, including its lead clinical asset laru‑zova (AGTC‑501) for X‑linked retinitis pigmentosa. The company’s focus is on delivering ophthalmic gene‑therapy products for patients with rare and prevalent retinal disorders. | Healthcare & Life Sciences | London | Confirmed | 2025-08-17 |
Backs Similar Companies
Investors who tend to invest in the same sort of companies.
5 more similar investors hiddenSign up to unlock →
Shareholding changes (19)
Syncona Portfolio Limited's positions across portfolio companies2026
- SERIES B3 PREFERRED 0 → 24,981,371
- SERIES C PREFERRED 0 → 1,341,703
- ORDINARY 5,601,000 → 15,981,005
Articles (4)
- Mosaic Therapeutics secures £20.7m growth capital for oncology medicines5 Sept 2026Mosaic Therapeutics
- Advent Life Sciences Fund III takes 3.1% of Beacon Therapeutics21 Aug 2026Beacon Therapeutics Holdings
- Slingshot Therapeutics reaches £18.3m valuation following latest funding10 Aug 2026Slingshot Therapeutics Holdings
- Mosaic Therapeutics Secures £261.4k Growth Funding Amidst Evolving UK Biotech Landscape24 Apr 2026Mosaic Therapeutics